Aziyo Biologics launches bone matrix for orthopedic surgery

Regenerative medicine company Aziyo Biologics on June 29 launched OsteoGro V, a viable cell bone matrix to assist with bone repair.

Advertisement

Three things to know:

1. OsteoGro V features cancellous bone particles and demineralized cortical bone particles and fibers to improve product handling.

2. Aziyo Biologics has entered into several private-label distribution agreements, which is expected to boost adoption in the spine, orthopedic and dental markets. 

3. Founded in 2015, Aziyo Biologics’ products focus on improving outcomes in implantable device- related complications.

More articles on biologics:
7 celebrity spine surgeries and who performed them — Drs. Robert Watkins, Richard Guyer & more
The future of private practice and payers in spine: 3 key thoughts
Texas hospital suspends construction of $120M spine tower due to economic challenges

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.